transplantation autologous syngeneic allogeneic xenogeneic

36
Transplantation •Autologous •Syngeneic •Allogeneic •Xenogeneic

Upload: marshall-randall

Post on 15-Jan-2016

245 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Transplantation

•Autologous

•Syngeneic

•Allogeneic

•Xenogeneic

Page 2: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Routinely performed transplantations:

•Kidney

•Heart

•Liver

•Lungs

•Pancreas

•Small bowel

•Hematopoetic stem cells

Page 3: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Occasionally performed transplantations:

•Hand

•Face

•Larynx (”voice box”)

Page 4: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Main problem in transplantation: Immune system attacks transplant.

Transplantation antigens:

HLA

ABO

Minor histocompatibility antigens

Page 5: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Transplant rejection is an immunological reaction.

Page 6: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Figure 16-2 The genetics of graft rejection. In the illustration, the two different mouse colors represent inbred strains with different MHC haplotypes. Inherited MHC alleles from both parents are codominantly expressed in the skin of an A × B offspring, and therefore these mice are represented by both colors. Syngeneic grafts are not rejected (A). Allografts are always rejected (B). Grafts from a parent of an A × B mating will not be rejected by the offspring (C), but grafts from the offspring will be rejected by either parent (D). These phenomena are due to the fact that MHC gene products are responsible for graft rejection; grafts are rejected only if they express an

MHC type (represented by a color) that is not expressed by the recipient mouse.

Downloaded from: StudentConsult (on 12 March 2008 09:15 AM)

© 2005 Elsevier

The genetics of graft rejection.

Page 7: Transplantation Autologous Syngeneic Allogeneic Xenogeneic
Page 8: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Direct recognition: Cross-reaction by a normal TCR, which was selected to recognize self MHC plus foreign peptide.

Page 9: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

About 2% of T-cells will react with a cell with foreign MHC molecules:

•One MHC can activate many T-cells

•Allogeneic MHC bind many peptides

•High density of epitopes

•Many memory cells activated

Page 10: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Direct allo-recognition.

MHC

MHC + peptide

Page 11: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Activation of alloreactive T cells.

Page 12: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

MLR

Page 13: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Transplant rejection

•Hyperacute (preformed antibodies)

•Acute (T cell activation)

•Chronic

Page 14: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Immune mechanisms of graft rejection.

Page 15: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Prevention of hyperacute rejection:

ABO typing

Cross-match (recipient serum, donor leukocytes)

Page 16: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Organ transplant recipients need life-long immunosuppression.

Page 17: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Immunosuppression

Page 18: Transplantation Autologous Syngeneic Allogeneic Xenogeneic
Page 19: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Kidney transplants: Transplantation centres cooperate so that kidneys are given to patients with most similar HLA.

Page 20: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Influence of HLA matching on graft survival.

Page 21: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Once removed from the donor, the kidney must be transplanted within 24-48 hours.

Page 22: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Main complications of immunosuppression:

Increased risk of infection

Increased risk of cancer

Drug toxicity

Page 23: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Xenografts:

Still not possible.Very strong immune reactions.Preformed (natural) antibodies to carbohydrate endothelium antigens – discordant species. For instance man and pig.

Page 24: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Transfusion: the process of transferring whole blood or blood components from one person (donor) to another (recipient).

Blood components: Red blood cells, thrombocytes or plasma.

Page 25: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Three allelic glycosyltransferases ; A, B and O (non-functional) determine the ABO blood type.

Page 26: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

ABO blood group antigens.

Page 27: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Natural antibodies in the ABO system:

A individuals: Anti B

B individuals: Anti A

AB individuals: None

O individuals: Anti A and anti B

Page 28: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Universal donors

Universal recipients

Transfusion of red blood cells

Page 29: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Transfusion of plasma

Page 30: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Rh(D) immunization

(No natural antibodies)

Page 31: Transplantation Autologous Syngeneic Allogeneic Xenogeneic
Page 32: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

(Bone marrow transplantation)

= Stem cell transplantation

Autologous/Allogeneic

Leukemia, immune deficiency, aplastic anemia

Page 33: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

HLA, but not ABO matching essential. MLR.

Bone marrow registries

Conditioning, harvesting.

Intravenous injection

Aplasia phase – infection risk

Page 34: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Graft versus host disease main complication.

If treatment is successful, permanent immunosuppression is not necessary, but immunodeficiency and infections may be a problem.

Page 35: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Two mistakes in Abbas’ textbook:

1. Page 374: ”Today, hyperacute rejection by anti-ABO antibodies is extremely rare because all donor and recipient pairs are selected so that they have the same ABO type.”

Identity is not necessary, compatibility is sufficient. For instance, a donor with blood group O can donate a kidney to a recipient with bl.gr. A.

Page 36: Transplantation Autologous Syngeneic Allogeneic Xenogeneic

2. Page 381: ”HLA matching in renal transplantation is possible because donor kidneys can be stored in organ banks before transplantation until a well-matched recipient can be identified..”

This is just fantasy! Kidney ”organ banks” has never existed. Kidneys must be used within 24-48 hours.